Gene Editing Ethical Considerations
- What happens to our societal structure when endowments that came via random lottery are no longer random? What will happen to our feelings of empathy and acceptance?
Jennifer Doudna
- Family Diary of struggles
- Study in 2019 of more than six million articles with women as the principal author showed that they are less likely to use self-promotional terms, such as “novel” and “unique” and “unprecedented,” to describe their findings.
CRISPR
- The one Doudna and others developed in 2012 was based on a virus fighting trick used by bacteria, which have been battling viruses for more than a billion years. In their DNA, bacteria develop clustered repeated sequences known as CRISPRs.
- DNA as repository of genetic information was made in 1944 by Oswald Avery and colleagues at Rockefeller University in New York. By extracting DNA from a strain of bacteria, mixing it with other, they showed that DNA transmitted inheritable transformations.
- Innovation using cross-study has been very integral in Biology.
- Bacterias in soil are able to communicate and join when they are starved for nutrients.
- RNA was just seen as messenger molecule that carries instructiions from DNA that is nestled in the nucleus of cells. So, small segment of DNA that encodes a gene is transcribed into snippet of RNA, which then travels to manufacturing region of the cell. Then it facilitates the assembly of proper sequence of amino acids to make a specified protien.
- Cech and Altman discovered that there were certain RNA introns that were self-splicing.
- Doudna used many tactics to create an RNA enzyme, or ribozyme, that could stitch together little RNA pieces. She and Szostak engineered a ribozyme that could splice together a copy a itself.
- Transposons or jumping genes which can change their position in a genome.
- RNA is made up of very few chemicals, so it accomplishes complex tasks based on the different ways it is folded. One of the challenges with RNA is that it’s a molecule made of only four chemical building blocks, unlike proteins, which have twenty.
- RNA interference: Normally the genes encoded by DNA in cells dispatch messenger RNAs to direct the building of a protein. RNA interference is when small molecules find a way to mess with these messenger RNAs. It operates by deploying an enzyme called “Dicer”. Dicer sinps a long piece of RNA into short fragments. Then these fragments do a search and destroy mission: seek out a messenger molecule that has matching letters, then they use a scissors-like enzyme to chop it up. Then that genetic information carried by that messenger RNA is silenced.
- Later spanish scientist also discribed a different virus fighting mechanism that didn’t work with RNA interference, but much more interesting.
- Ishino found that there were five identical segments of DNA in bacterias which usually have very less amount of DNA material to begin with. So, this had to be something important. These were “spacers”.
- Mojica named it “Clustered regularly interspaced short pallindromic repeats”
- When he searched for spacers in previous databases, he found that those segments matched sequences that were in viruses that attacked E. Coli. Other bacterias had this crispr sequence as well.
- Bacterias were taking the virus’s DNA and acquired immunity to that new virus.
- DNAs and protiens alike cannot be defined just by their sequence: you need to know how its folded in terms of its structure.
- Enzymes are protiens that spark chemical reactions in the cells of living beings. There are 5000+ biochemical reactions catalyzed by enzymes. e.g. Breaking down starches and protiens, causing muscle contractions, regulating metabolism, and in this case: cutting and splicing DNA and RNA.
- These CRISPR associated enzymes also known as Cas. enzymes enable the system to cut and paste new memories of viruses that attack that bacteria. They create short segments of RNA called CRISPR RNA (crRNA) that can guide a scissors-like enzyme to dangerous virus and cut up its genetic material.
- By the time Gentech was hiring Doudna, the company already was worth 100 billion.
- RNA hairpin where Cas6 could interact with just the right sequence.
- Charpentier, on the other hand, was more nomadic. Since she felt more like foreigner, she found more delight in her work than anything else.
- A gene known as P53 encodes for a protein that suppresses the growth of cancerous tumors. It helps the body respond to damaged DNA and prevents cancerous cells from dividing. Cancers proliferates if something goes wrong with this gene.
- Elephants have 20 copies of this gene and rarely get cancer.
- Zayner, biotechnology at home.
- Then they found anti CRISPR cas9s that would inhibit or stop the editing. That made sure that process could be much more.
- And with gene therapy there were incidents where people died due to immune response which made it more challenging to work with and continue progress.
Highlights
One of the leaders she tapped was a postdoc named Jennifer Hamilton who, a few months earlier, had spent a day teaching me to use CRISPR to edit human genes. I was pleased, but also a bit unnerved, to see how easy it was. Even I could do it!
What might that do to the diversity of our societies? If we are no longer subject to a random natural lottery when it comes to our endowments, will it weaken our feelings of empathy and acceptance
these offerings at the genetic supermarket aren’t free (and they won’t be), will that greatly increase inequality—and indeed encode it permanently in the human race
These revolutions arose from the discovery, beginning just over a century ago, of the three fundamental kernels of our existence: the atom, the bit, and the gene.
The gene-editing tool that Doudna and others developed in 2012 is based on a virus-fighting trick used by bacteria, which have been battling viruses for more than a billion years. In their DNA, bacteria develop clustered repeated sequences, known as CRISPRs
There are other star players in the field of gene editing. Most of them deserve to be the focus of biographies or perhaps even movies. (The elevator pitch: A Beautiful Mind meets Jurassic Park.) They play important roles in this book, because I want to show that science is a team sport. But I also want to show the impact that a persistent, sharply inquisitive, stubborn, and edgily competitive player can have
She has the instincts to be collaborative, as any scientist must, but ingrained in her character is a competitive streak, which most great innovators have
Research about surface-state physics eventually led to the transistor and microchip. Likewise, studies of an astonishing method that bacteria use to fight off viruses eventually led to a gene-editing tool and techniques that humans can use in their own struggle against viruses
A tale that became part of the family lore involved one of Jennifer’s great-grandmothers. She was part of a family of three brothers and three sisters. Their parents could not afford for all six to go to school, so they decided to send the three girls. One became a teacher in Montana and kept a diary that has been handed down over the generations. It is filled with tales of perseverance, broken bones, working in the family store, and other frontier endeavors. “She was crusty and stubborn and had a pioneering spirit,” said Jennifer’s sister Sarah, the current generation’s keeper of the diary
When he earned his doctorate, he applied for fifty jobs and got only one offer, from the University of Hawaii at Hilo. So he borrowed $900 from his wife’s retirement fund and moved his family there in August 1971, when Jennifer was seven
We all see nature’s wonders every day, whether it be a plant that moves or a sunset that reaches with pink fingers into a sky of deep blue. The key to true curiosity is pausing to ponder the causes. What makes a sky blue or a sunset pink or a leaf of sleeping grass curl?
That’s a good analogy to how I’ve approached my work,” she said. “I’ve looked for opportunities where I can fill a niche where there aren’t too many other people with the same skill sets.
He knew that horses and cows near his childhood home in rural England were occasionally born with slight variations, and over the years breeders would select the best to produce herds with more desirable traits. Perhaps nature did the same thing. He called it “natural selection
Isaac Asimov later noted concerning the genesis of evolutionary theory, “What you needed was someone who studied species, read Malthus, and had the ability to make a cross-connection.”3
The following year he experimented with something new: breeding together plants with differing traits, such as those that had white flowers with those that had violet ones. It was a painstaking task that involved snipping off each of the plant’s receptors with forceps and using a tiny brush to transfer pollen
What his experiments showed was momentous, given what Darwin was writing at the time. There was no blending of traits. Tall plants cross-bred with short ones did not produce medium-size offspring, nor did purple-flowered plants cross-bred with white-flowered ones produce some pale mauve hue. Instead, all the offspring of a tall and a short plant were tall. The offspring from purple flowers crossbred with white flowers produced only purple flowers. Mendel called these the dominant traits; the ones that did not prevail he called recessive
The primary discovery that fingered DNA as the repository of genetic information was made in 1944 by the biochemist Oswald Avery and his colleagues at Rockefeller University in New York. They extracted DNA from a strain of bacteria, mixed it with another strain, and showed that the DNA transmitted inheritable transformations.
At the University of Chicago, which he entered at fifteen, he planned to indulge his love of birds, and his aversion to chemistry, by becoming an ornithologist. But in his senior year he read a review of What Is Life?, in which the quantum physicist Erwin Schrödinger turned his attention to biology to argue that discovering the molecular structures of a gene would show how it hands down hereditary information through generations
Suddenly I was excited about chemistry,” Watson recalled. “I knew that genes could crystallize; hence they must have a regular structure that could be solved in a straightforward fashion.” For the next couple of days, Watson stalked Wilkins with the hope of cadging an invitation to join his lab, but to no avail
Adding to Watson’s dismay was the news that Linus Pauling was coming over from Caltech to lecture in England, which would likely catalyze his own attempt to solve the structure of DNA. Fortunately, the U.S. State Department came to the rescue. In the weirdness engendered by red-baiting and McCarthyism, Pauling was stopped at the airport in New York and had his passport confiscated because he had been spouting enough pacifist opinions that the FBI thought he might be a threat to the country if allowed to travel. So he never got the chance to discuss the crystallography work done in England, thus helping the U.S. lose the race to figure out DNA.
Watson and Crick finished their paper on the last weekend of March 1953. It was a mere 975 words, typed by Watson’s sister, who was persuaded to do so by his argument that “she was participating in perhaps the most famous event in biology since Darwin’s book
There was a thread that wove together her childhood curiosity about the eyeless spiders in the lava tubes, the sleeping grass that curled when you touched it, and the human cells that became cancerous: they were all connected to the detective story of the double helix
Many of her classmates came from wealthy Southern California families and had their own cars, while she was on a scholarship and worked part time to pay her living expenses
She thought about changing her major to French. “I went to talk to my French teacher about that, and she asked what I was majoring in.” When Doudna replied that it was chemistry, the teacher told her to stick with it. “She was really insistent. She said ‘If you major in chemistry you’ll be able to do all sorts of things. If you major in French you will be able to be a French teacher
Panasenko was studying a topic that aligned with Doudna’s interest in the mechanisms of living cells: how some bacteria found in soil are able to communicate so that they can join together when they are starved for nutrients. They form a commune called a “fruiting body
At the time of the Human Genome Project, RNA was seen as mainly a messenger molecule that carries instructions from the DNA that is nestled in the nucleus of the cells. A small segment of DNA that encodes a gene is transcribed into a snippet of RNA, which then travels to the manufacturing region of the cell. There this “messenger RNA” facilitates the assembly of the proper sequence of amino acids to make a specified protein
Francis Crick, five years after co-discovering the structure of DNA, came up with a name for this process of genetic information moving from DNA to RNA to the building of proteins. He dubbed it the “central dogma” of biology. He later conceded that “dogma,” which implies an unchanging and unquestioned faith, was a poor choice of words.1 But the word “central” was apt. Even as the dogma was modified, the process remained central to biology
Cech and Altman discovered that there were certain RNA introns that were self-splicing! This had pretty cool implications. If some RNA molecules could store genetic information and also act as a catalyst to spur chemical reactions, they might be more fundamental to the origins of life than DNA, which cannot naturally replicate themselves without the presence of proteins to serve as a catalyst
Szostak’s excitement about discovering how life began taught Doudna a second big lesson, in addition to taking risks by moving into new fields: Ask big questions. Even though Szostak liked diving into the details of experiments, he was a grand thinker, someone who was constantly pursuing truly profound inquiries. “Why else would you do science?” he asked Doudna. It was an injunction that became one of her own guiding principles
Doudna used many tactics to create an RNA enzyme, or ribozyme, that could stitch together little RNA pieces. Eventually, she and Szostak were able to engineer a ribozyme that could splice together a copy of itself
On one of the important papers that she helped produce for the journal Science in 1989, Doudna’s name appears in the middle of the list because she was mentoring a lucky Harvard undergraduate who worked in the lab part time, and she felt that the student should be the featured lead author
. It was the biologist Barbara McClintock, who had been a researcher at Cold Spring Harbor for more than forty years and had recently been awarded the Nobel Prize for her discovery of transposons, known as “jumping genes,” that can change their position in a genome
One breakthrough came as a result of the random things that often happen in science: a slight blunder, like the mold that got on Alexander Fleming’s Petri dishes and led to the discovery of penicillin. One day a technician was working with Doudna to try to make crystals, and she put the experiment into an incubator that was not working properly. They thought the experiment was spoiled, but when they looked at the samples through a microscope they could see crystals growing. “The crystals had RNA in them and were beautiful,” Doudna recalled, “and that was the first breakthrough showing us that to get these crystals we had to elevate the temperature.”
RNA is made up of very few chemicals, so it accomplishes complex tasks based on the different ways it is folded. One of the challenges with RNA is that it’s a molecule made of only four chemical building blocks, unlike proteins, which have twenty
Bonds can take different forms, both in chemistry and in life. Sometimes an intellectual bond is the strongest
Yale tried hard to keep Doudna, promoting her to an important professorship. To resolve what is known as the “two-body problem” in academia, it offered Cate a position as well. However, Tom Steitz, the structural biologist who had shown them the techniques of cryocooling, was there doing the same type of research Cate wanted to do, and he felt that would crimp his chance to flourish. “My direct competitor was there,” Cate says. “He’s a great guy, but it would be hard to be in the same institution.
Doudna also became interested in a phenomenon known as RNA interference. Normally, the genes encoded by the DNA in cells dispatch messenger RNAs to direct the building of a protein. RNA interference does just what the name implies: small molecules find a way to mess with these messenger RNAs.
RNA interference was discovered in the 1990s, partly by researchers who were trying to make petunias more purple by juicing up the flower’s color genes. But the process ended up suppressing some of the genes, leading to mottled and speckled petunias. Craig Mello and Andrew Fire coined the term “RNA interference” in a 1998 paper and later won the Nobel Prize when they discovered how the phenomenon works in the nematode, a tiny worm
RNA interference operates by deploying an enzyme known as “Dicer.” Dicer snips a long piece of RNA into short fragments. These little fragments can then embark on a search-and-destroy mission: they seek out a messenger RNA molecule that has matching letters, then they use a scissors-like enzyme to chop it up. The genetic information carried by that messenger RNA is thus silenced
Doudna’s paper on RNA interference appeared in Science in January 2006. A few months later, a paper published in a little-known journal described a different virus-fighting mechanism that exists in nature. It was by an obscure Spanish scientist who discovered the mechanism in microorganisms like bacteria, which have a far longer and even more brutal history fighting viruses than we humans do. At first, the handful of scientists studying this system assumed that it worked through RNA interference. They would soon discover that the phenomenon was even more interesting
The scientist does not study nature because it is useful. He studies it because he takes pleasure in it, and he takes pleasure in it because it is beautiful. —Henri Poincaré, Science and Method, 1908
he found five segments of DNA that were identical to each other. These repeated sequences, each twenty-nine base pairs long, were sprinkled between normal-looking sequences of DNA, which he called “spacers.” Ishino had no idea what these clustered repeats were
But he knew that bacteria and archaea have small amounts of genetic material. They cannot afford to waste a lot of it on sequences that have no important function. So he kept trying to figure out the purpose of these clustered repeats. Perhaps they helped shape the DNA structure or formed loops that proteins could latch on to. Both of those speculations also proved wrong
Mojica was driving home from his lab one evening when he came up with the name CRISPR, for “clustered regularly interspaced short palindromic repeats.”
What fascinated him were the “spacers,” those regions of normal-looking DNA segments that were nestled in between the repeated CRISPR segments. He took the spacer sequences of E. coli and ran them through databases. What he found was intriguing: the spacer segments matched sequences that were in viruses that attacked E. coli. He found the same thing when he looked at other bacteria with CRISPR sequences; their spacer segments matched those of viruses that attacked that bacteria. “Oh my goodness!” he exclaimed at one point
When new viruses came along, the bacteria that survived were able to incorporate some of that virus’s DNA and thus create, in its progeny, an acquired immunity to that new virus. Mojica recalls being so overcome by emotion at this realization that he got tears in his eyes.8 The beauty of nature can sometimes do that to you
We had to determine structures, because structures, the folds and shapes, are conserved over a longer evolutionary period than the nucleic acid sequences.” In other words, the sequence of letters in the DNA did not reveal how it worked; what was important was how it folded and twisted, which would reveal how it interacted with other molecules
At 4 a.m., after working all night, Wiedenheft organized a tricycle race around the entire circuit of the building, which he of course won
Enzymes are a type of protein. Their main function is to act as a catalyst that sparks chemical reactions in the cells of living organisms, from bacteria to humans. There are more than five thousand biochemical reactions that are catalyzed by enzymes. These include breaking down starches and proteins in the digestive system, causing muscles to contract, sending signals between cells, regulating metabolism, and (most important for this discussion) cutting and splicing DNA and RNA
These CRISPR-associated (Cas) enzymes enable the system to cut and paste new memories of viruses that attack the bacteria. They also create short segments of RNA, known as CRISPR RNA (crRNA), that can guide a scissors-like enzyme to a dangerous virus and cut up its genetic material. Presto! That’s how the wily bacteria create an adaptive immune system
There is some truth to the linear model. Basic research in quantum theory and surface-state physics of semiconducting materials led to the development of the transistor. But it wasn’t quite that simple or linear. The transistor was developed at Bell Labs, the research organization of the American Telephone and Telegraph Company. It employed many basic science theorists, such as William Shockley and John Bardeen. Even Albert Einstein dropped by. But it also threw them together with practical engineers and pole-climbers who knew how to amplify a phone signal. Added to the mix were business development executives who pushed ways to enable long-distance calls across the continent. All of these players informed and prodded each other
Matt Ridley points out in his book How Innovation Works, sometimes it’s a two-way street. “It is just as often the case that invention is the parent of science: techniques and processes are developed that work, but the understanding of them comes later,” he writes. “Steam engines led to the understanding of thermodynamics, not the other way round. Powered flight preceded almost all aerodynamics.
As Doudna and her team began working on CRISPR, two young food scientists on different continents were studying CRISPR with the goal of improving ways to make yogurt and cheese
They used these discoveries in August 2005 to apply for and get one of the first patents granted for CRISPR-Cas systems. That year Danisco started using CRISPR to vaccinate its bacterial strains
The year of the inaugural conference produced a major advance. Luciano Marraffini and his advisor Erik Sontheimer of Northwestern University in Chicago showed that the target of the CRISPR system was DNA. In other words, CRISPR did not work through RNA interference, which had been the general consensus when Banfield first approached Doudna. Instead, the CRISPR system targeted the DNA of the invading virus
There was still a lot to figure out before that could happen. Marraffini and Sontheimer didn’t know precisely how the CRISPR enzyme cut the DNA. It could have done so in a way that was incompatible with genetic editing. Nevertheless, they filed a patent application in September 2008 for the use of CRISPR as a DNA-editing tool. It was rejected, and rightly so. Their guess that it could someday be a gene-editing tool was correct, but it was not yet backed up by experimental evidence. “You can’t just patent an idea
Bored and still a bit hungry after their conference dinner one night, they walked to a New York–style deli, with a neon sign reading “Shalom” rather than the usual “Aloha,” in a strip mall near Waikiki Beach. Over pastrami sandwiches, they brainstormed how to combine their discoveries to create a method for engineering and manufacturing new genes. They agreed to work together on the idea, and within four months they had spliced together DNA fragments from different organisms and cloned millions of them, giving birth to the field of biotechnology and launching the genetic engineering revolution.2
One of Stanford’s alert intellectual property lawyers approached them and, to their surprise, offered to help them file a patent application. In 1974 they did, and it was eventually approved
In late 1975, a year after the Cohen-Boyer patent application was filed, a struggling young wannabe venture capitalist named Robert Swanson started making unsolicited phone calls to scientists who might be interested in starting a genetic engineering company
Boyer wisely rejected that and suggested instead that they call it Genentech, a mash-up of “genetic engineering technology.” It began making genetically engineered drugs and, in August 1978, blasted into hypergrowth when it won a bet-the-company race to make a synthetic version of insulin to treat diabetes
portrait painting of a smiling Boyer appeared on the cover of Time with the headline “The Boom in Genetic Engineering.” It came out the same week that Prince Charles of England picked Diana to be his princess, an event that, in those more rarefied times for journalism, received only a secondary mention on the magazine’s cover
Genentech’s success led to a memorable front page of the San Francisco Examiner in October 1980, when the company became the first biotech company to launch an IPO and become publicly traded. Its stock, trading under the symbol GENE, opened at $35 a share and within an hour was selling at $88. “Genentech Jolts Wall Street,” the banner front-page headline blared
By the time Genentech began recruiting Doudna in late 2008, the company was worth close to $100 billion
once asked Steve Jobs what his best product was, thinking he would say the Macintosh or iPhone. Instead he said that creating great products is important, but what’s even more important is creating a team that can continually make such products
This transition from player to coach happens in many fields. Writers become editors, engineers become managers. When bench scientists become lab heads their new managerial duties include hiring the right young researchers, mentoring them, going over their results, suggesting new experiments, and offering up the insights that come from having been there
their paper, they called it “an unexpected recognition mechanism.” There was an “RNA hairpin” where the Cas6 could interact with just the right sequence. Once again, the twists and folds of a molecule’s shape were the key in discovering how it worked
When Ross Wilson, a newly minted PhD from Ohio State, applied to be a postdoctoral fellow in Doudna’s lab, Jinek pulled him aside to give him a word of warning. “You have to be self-sufficient,” he told Wilson. “If you’re not self-motivated, Jennifer is not going to help you much or do the work for you. At times she will seem disengaged. But if you’re a self-starter, she will give you the chance to take risks, provide really smart guidance, and be there when you need her.
study in 2019 of more than six million articles with women as the principal author showed that they are less likely to use self-promotional terms, such as “novel” and “unique” and “unprecedented,” to describe their findings
the highest-impact journals that publish the most important cutting-edge research, women are 21 percent less likely to use positive and self-promotional words in describing their work. Partly as a result, their papers are cited approximately 10 percent less frequently
With prodding from its provost Frederick Terman, Stanford professors were encouraged to turn their discoveries into startups
s hard to imagine Steve Jobs or Mark Zuckerberg joining such a support group, but Haurwitz, like her mentor Doudna, had a self-awareness and humility not usually found among alpha males
As World War II was ending, the great engineer and public official Vannevar Bush argued that America’s innovation engine would require a three-way partnership of government, business, and academia
He was uniquely qualified to envision that triangle, because he had a foot in all three camps. He had been dean of engineering at MIT, a founder of Raytheon, and the chief government science administrator overseeing, among other projects, the building of the atom bomb
Also like the arts, once a scientist masters the basic routine, she has to combine it with creativity. “You have to be rigorous and disciplined,” Charpentier explains, “but also know when to let yourself loose and blend in a creative approach. I found in biological research the right combination of persistence and creativity
the years since she entered the Pasteur Institute in 1992, Charpentier had worked in ten institutions in seven cities in five countries. Her nomadic life reflected the fact, and reinforced the fact, that she resisted bonds. With no spouse or family, she sought out changing environments and adapted to them without any inhibiting personal ties. “I enjoy the freedom of being on my own, of not depending on partnership,” she says. She hated the phrase “work-life balance” because it implied that work competes with life. Her work in the lab and her “passion for science,” she says, brought her a “happiness that is as fulfilling as any other passion
Moving also made her feel like a bit of a foreigner most of the time, the way the young Jennifer Doudna felt as a child in Hawaii. “It’s important to know how to be an outsider,” Charpentier says. “You’re never completely at home, and that can drive you. It can challenge you not to seek being comfortable.” As
For example, a gene known as P53 encodes for a protein that suppresses the growth of cancerous tumors. It helps the body respond to damaged DNA and prevents cancerous cells from dividing. Humans tend to have one copy of this gene, and cancers proliferate if something goes wrong with it
Elephants have twenty copies of this gene, and they almost never get cancer
In most cases, the biohackers are, like Zayner, accomplished scientists who forgo working at universities or corporations and instead become the rogue wizards of a rarefied part of the do-it-yourself maker’s movement. In the drama of CRISPR, Zayner plays the role of one of Shakespeare’s wise fools, such as Puck in A Midsummer Night’s Dream, who speaks truth under the guise of showmanship, pokes fun at the pretensions of the high-minded, and pushes us forward by pointing out what fools these mortals be
’t it dangerous, I ask, for everyone to have access to this technology? “No, it’s fucking exciting,” he counters. “No great technology has flourished until people had complete access to it.” He has a point. What truly caused the digital age to blossom was when computers became personal. It happened in the mid-1970s with the advent of the Altair and the Apple II, devices that democratized control of computing power. First hackers and then the rest of us got to play with our own computers and produce digital content. The digital revolution was kicked into an even higher orbit in the early 2000s with the birth of the smartphone. As Zayner says, “Once we have people doing biotechnology at home, like we did with computer programming, so many amazing things will be contributed
In other words, bacteria developed CRISPR systems to ward off viruses, but then the viruses developed a way to shut down those defenses. It was an arms race the Pentagon could understand: missiles being countered by defense systems being countered by anti–defense systems. The newly discovered systems were dubbed “anti-CRISPRs
His anti-CRISPRs didn’t seem to work on CRISPR-Cas9, so the discovery got little attention at first. But in 2016, he and April Pawluk, who had worked with him on the original paper, identified anti-CRISPRs that disabled the Cas9 enzyme. That opened the floodgates for other researchers to join the hunt, and soon more than fifty anti-CRISPR proteins had been discovered. By then Bondy-Denomy had become a professor at the University of California, San Francisco, and he collaborated with Doudna’s lab to show that the anti-CRISPRs could be delivered into human cells to modulate or stop CRISPR-Cas9 editing
any method would be foolproof. So they issued a letter—which was signed by Berg, James Watson, Herbert Boyer, and others—calling for a “moratorium” on the creation of recombinant DNA until safety guidelines could be formulated
Asilomar was a great success. It paved the way for genetic engineering to become a booming field. But Chargaff’s mocking assessment pointed to another lasting legacy. Asilomar became notable for what the scientists did not discuss there. Their focus was on safety. None of them addressed the big ethical question, the one that Berg had stayed up late discussing in Sicily: How far should we go if and when methods of engineering our genes turned out to be safe?
was unlikely that the therapy would help Gelsinger right away, because it was a trial designed to see how the therapy could be used to save babies. But it offered him hope that someday he would be able to eat hot dogs, and in the meantime, some babies would be saved. “What’s the worst that can happen to me?” he said to a friend as he was leaving for the Philadelphia hospital. “I die, and it’s for the babies.”23 Unlike the seventeen other humans in the trial, Gelsinger had a massive immune response caused by the virus transporting the therapeutic gene, which resulted in a high fever followed by the breakdown of his kidneys, lungs, and other organs. In four days he was dead. Work on gene therapy ground to a halt. “We were all very much aware of what happened,” Doudna recalled. “That made the whole field of gene therapy go away, mostly, for at least a decade. Even the term gene therapy became kind of a black label. You didn’t want that in your grants. You didn’t want to say, ‘I’m working on gene therapy.’ It sounded terrible